Jørgen Schøller
JS
Jørgen Schøller
CEO at VPCIR Biosystems
Rate
About
Jørgen Schøller is the CEO of VPCIR Biosystems, a company focused on developing new and more sensitive diagnostic technology for commercial use, particularly for detecting tuberculosis through saliva. He has been involved in the development of diagnostic technologies for infectious diseases for many years, including the Dextramer technology at Immudex.
Frequently asked
Who is Jørgen Schøller?
Jørgen Schøller is the CEO of VPCIR Biosystems, a company focused on developing new and more sensitive diagnostic technology for commercial use, particularly for detecting tuberculosis through saliva. He has been involved in the development of diagnostic technologies for infectious diseases for many years, including the Dextramer technology at Immudex.
What is Jørgen Schøller's current role?
Jørgen Schøller is currently CEO at VPCIR Biosystems.
Comments
No comments yet. Be the first to share your take.
Profile
About Jørgen Schøller
Jørgen Schøller is CEO at VPCIR Biosystems. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.